BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26749573)

  • 21. Clusterin plays an important role in clear renal cell cancer metastasis.
    Wang X; Luo L; Dong D; Yu Q; Zhao K
    Urol Int; 2014; 92(1):95-103. PubMed ID: 24008723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulated fascin1 in non-small cell lung cancer promotes the migration and invasiveness, but not proliferation.
    Zhao J; Zhou Y; Zhang Z; Tian F; Ma N; Liu T; Gu Z; Wang Y
    Cancer Lett; 2010 Apr; 290(2):238-47. PubMed ID: 19819618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TGF-beta promotes the establishment of renal cell carcinoma bone metastasis.
    Kominsky SL; Doucet M; Brady K; Weber KL
    J Bone Miner Res; 2007 Jan; 22(1):37-44. PubMed ID: 17032147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TGF-beta1 promotes migration and invasion of salivary adenoid cystic carcinoma.
    Dong L; Wang YX; Li SL; Yu GY; Gan YH; Li D; Wang CY
    J Dent Res; 2011 Jun; 90(6):804-9. PubMed ID: 21441221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor-beta1 and renal cell cancer: cell growth, mRNA expression and protein production of cytokines.
    Shimabukuro T; Ohmoto Y; Naito K
    J Urol; 2003 May; 169(5):1865-9. PubMed ID: 12686863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer.
    Vignjevic D; Schoumacher M; Gavert N; Janssen KP; Jih G; Laé M; Louvard D; Ben-Ze'ev A; Robine S
    Cancer Res; 2007 Jul; 67(14):6844-53. PubMed ID: 17638895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1.
    Picon A; Gold LI; Wang J; Cohen A; Friedman E
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):497-504. PubMed ID: 9641494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforming growth factor-beta downregulates interleukin-2-induced phosphorylation of signal transducer and activator of transcription 5 in human renal cell carcinoma.
    Song C; Jun SY; Hong JH; Ahn H
    J Cancer Res Clin Oncol; 2007 Jul; 133(7):487-92. PubMed ID: 17279417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
    Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visualisation of transforming growth factor-beta 1, tissue kallikrein, and kinin and transforming growth factor-beta receptors on human clear-cell renal carcinoma cells.
    Moodley R; Snyman C; Odhav B; Bhoola KD
    Biol Chem; 2005 Apr; 386(4):375-82. PubMed ID: 15899700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of regulating TGF-β1/Smad signaling pathway on apoptosis of hepatocellular carcinoma HepG2 cells under endoplasmic reticulum stress].
    Huang YW; Xiong L; Dou Y; Lyu MJ; Ma YH
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 May; 37(3):266-271. PubMed ID: 34374239
    [No Abstract]   [Full Text] [Related]  

  • 32. [Jiedu sangen decoction intervened carcinoma-associated fibroblasts and inhibited migration and invasion of colon cancer: an experimental research].
    Ruan SM; Shen MH; Lin H; Zheng LP; Wang Y; Li MT
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Sep; 33(9):1242-6. PubMed ID: 24273982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of β-catenin gene silencing by shRNA on biologic characteristics of human esophageal carcinoma cells].
    Wang JS; Ji AF; Wen JF; Ren HZ
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):835-41. PubMed ID: 21215100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
    Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
    Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.
    Ren J; Li W; Liu H; Yan L; Jiao W; Li D; Tang Y; Gu G; Xu Z
    Urol Oncol; 2013 Oct; 31(7):1358-66. PubMed ID: 22341977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of hyperthermia on invasion ability and TGF-β1 expression of breast carcinoma MCF-7 cells.
    Xie X; Shao X; Gao F; Jin H; Zhou J; Du L; Zhang Y; Ouyang W; Wang X; Zhao L; Zhang X; Tang J
    Oncol Rep; 2011 Jun; 25(6):1573-9. PubMed ID: 21455587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel anti-invasive properties of a Fascin1 inhibitor on colorectal cancer cells.
    Montoro-García S; Alburquerque-González B; Bernabé-García Á; Bernabé-García M; Rodrigues PC; den-Haan H; Luque I; Nicolás FJ; Pérez-Sánchez H; Cayuela ML; Salo T; Conesa-Zamora P
    J Mol Med (Berl); 2020 Mar; 98(3):383-394. PubMed ID: 31996952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
    Ji F; Fu SJ; Shen SL; Zhang LJ; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
    BMC Cancer; 2015 Mar; 15():116. PubMed ID: 25880619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor beta1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma.
    Ananth S; Knebelmann B; Grüning W; Dhanabal M; Walz G; Stillman IE; Sukhatme VP
    Cancer Res; 1999 May; 59(9):2210-6. PubMed ID: 10232610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New role of the antidepressant imipramine as a Fascin1 inhibitor in colorectal cancer cells.
    Alburquerque-González B; Bernabé-García M; Montoro-García S; Bernabé-García Á; Rodrigues PC; Ruiz Sanz J; López-Calderón FF; Luque I; Nicolas FJ; Cayuela ML; Salo T; Pérez-Sánchez H; Conesa-Zamora P
    Exp Mol Med; 2020 Feb; 52(2):281-292. PubMed ID: 32080340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.